These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 15446805)

  • 1. Theoretical analysis of microdosimetric spectra and cluster formation for 103Pd and 125I photon emitters.
    Reniers B; Vynckier S; Verhaegen F
    Phys Med Biol; 2004 Aug; 49(16):3781-95. PubMed ID: 15446805
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Calculated microdosimetric characteristics of 125I and 103Pd brachytherapy seeds at different depths in water.
    Wuu CS; Chen J
    Radiat Prot Dosimetry; 2006; 122(1-4):506-8. PubMed ID: 17189276
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Brachytherapy dosimetry of 125I and 103Pd sources using an updated cross section library for the MCNP Monte Carlo transport code.
    Bohm TD; DeLuca PM; DeWerd LA
    Med Phys; 2003 Apr; 30(4):701-11. PubMed ID: 12722822
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sensitivity of low energy brachytherapy Monte Carlo dose calculations to uncertainties in human tissue composition.
    Landry G; Reniers B; Murrer L; Lutgens L; Gurp EB; Pignol JP; Keller B; Beaulieu L; Verhaegen F
    Med Phys; 2010 Oct; 37(10):5188-98. PubMed ID: 21089752
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Monte Carlo dosimetry for 125I and 103Pd eye plaque brachytherapy with various seed models.
    Thomson RM; Rogers DW
    Med Phys; 2010 Jan; 37(1):368-76. PubMed ID: 20175499
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comparison of radial dose functions for 103Pd, 125I, 145Sm, 241Am, 169Yb, 192Ir, and 137Cs brachytherapy sources.
    Meigooni AS; Nath R
    Int J Radiat Oncol Biol Phys; 1992; 22(5):1125-30. PubMed ID: 1555964
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Approaches to calculating AAPM TG-43 brachytherapy dosimetry parameters for 137Cs, 125I, 192Ir, 103Pd, and 169Yb sources.
    Melhus CS; Rivard MJ
    Med Phys; 2006 Jun; 33(6):1729-37. PubMed ID: 16872080
    [TBL] [Abstract][Full Text] [Related]  

  • 8. More accurate fitting of 125I and 103Pd radial dose functions.
    Taylor RE; Rogers DW
    Med Phys; 2008 Sep; 35(9):4242-50. PubMed ID: 18841874
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Edema-induced increase in tumour cell survival for 125I and 103Pd prostate permanent seed implants--a bio-mathematical model.
    Yue N; Chen Z; Nath R
    Phys Med Biol; 2002 Apr; 47(7):1185-204. PubMed ID: 11996063
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dose rate constant and energy spectrum of interstitial brachytherapy sources.
    Chen Z; Nath R
    Med Phys; 2001 Jan; 28(1):86-96. PubMed ID: 11213926
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Monte Carlo dosimetry for 125I and 103Pd eye plaque brachytherapy.
    Thomson RM; Taylor RE; Rogers DW
    Med Phys; 2008 Dec; 35(12):5530-43. PubMed ID: 19175111
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Some treatment planning considerations for 103Pd and 125I permanent interstitial implants.
    Nath R; Meigooni AS; Melillo A
    Int J Radiat Oncol Biol Phys; 1992; 22(5):1131-8. PubMed ID: 1555965
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A radiobiological investigation on dose and dose rate for permanent implant brachytherapy of breast using 125I or 103Pd sources.
    Baltas D; Lymperopoulou G; Löffler E; Mavroidis P
    Med Phys; 2010 Jun; 37(6):2572-86. PubMed ID: 20632569
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Microdosimetric evaluation of relative biological effectiveness for 103Pd, 125I, 241Am, and 192Ir brachytherapy sources.
    Wuu CS; Kliauga P; Zaider M; Amols HI
    Int J Radiat Oncol Biol Phys; 1996 Oct; 36(3):689-97. PubMed ID: 8948355
    [TBL] [Abstract][Full Text] [Related]  

  • 15. COMS eye plaque brachytherapy dosimetry simulations for 103Pd, 125I, and 131Cs.
    Melhus CS; Rivard MJ
    Med Phys; 2008 Jul; 35(7):3364-71. PubMed ID: 18697560
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Spectroscopic output of 125I and 103Pd low dose rate brachytherapy sources.
    Usher-Moga J; Beach SM; DeWerd LA
    Med Phys; 2009 Jan; 36(1):270-8. PubMed ID: 19235395
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The radial dose function of low-energy brachytherapy seeds in different solid phantoms: comparison between calculations with the EGSnrc and MCNP4C Monte Carlo codes and measurements.
    Reniers B; Verhaegen F; Vynckier S
    Phys Med Biol; 2004 Apr; 49(8):1569-82. PubMed ID: 15152693
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Isotope selection for patients undergoing prostate brachytherapy.
    Cha CM; Potters L; Ashley R; Freeman K; Wang XH; Waldbaum R; Leibel S
    Int J Radiat Oncol Biol Phys; 1999 Sep; 45(2):391-5. PubMed ID: 10487561
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dosimetric effects of seed anisotropy and interseed attenuation for 103Pd and 125I prostate implants.
    Chibani O; Williamson JF; Todor D
    Med Phys; 2005 Aug; 32(8):2557-66. PubMed ID: 16193786
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Monte Carlo calculation of dosimetry parameters for the IR08-103Pd brachytherapy source.
    Saidi P; Sadeghi M; Shirazi A; Tenreiro C
    Med Phys; 2010 Jun; 37(6):2509-15. PubMed ID: 20632562
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.